0001656536-20-000002.txt : 20201112 0001656536-20-000002.hdr.sgml : 20201112 20201112095515 ACCESSION NUMBER: 0001656536-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201112 DATE AS OF CHANGE: 20201112 EFFECTIVENESS DATE: 20201112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Decibel Therapeutics, Inc. CENTRAL INDEX KEY: 0001656536 IRS NUMBER: 464198709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-380289 FILM NUMBER: 201304222 BUSINESS ADDRESS: STREET 1: 1325 BOYLSTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02215 BUSINESS PHONE: 617-370-8701 MAIL ADDRESS: STREET 1: 1325 BOYLSTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02215 D 1 primary_doc.xml X0708 D LIVE 0001656536 Decibel Therapeutics, Inc. 1325 BOYLSTON STREET SUITE 500 BOSTON MA MASSACHUSETTS 02215 617-370-8701 DELAWARE None None Corporation true Laurence Reid 1325 Boyston Street Suite 500 Boston MA MASSACHUSETTS 02215 Executive Officer Director Elisabeth Leiderman 1325 Boyston Street Suite 500 Boston MA MASSACHUSETTS 02215 Executive Officer Peter A. Thompson 1325 Boyston Street Suite 500 Boston MA MASSACHUSETTS 02215 Director Neil Exter 1325 Boyston Street Suite 500 Boston MA MASSACHUSETTS 02215 Director Anthony Philippakis 1325 Boyston Street Suite 500 Boston MA MASSACHUSETTS 02215 Director Christine A. Poon 1325 Boyston Street Suite 500 Boston MA MASSACHUSETTS 02215 Director Biotechnology Decline to Disclose 06b false 2020-11-02 false true false 0 82199983 54800067 27399916 false 23 0 0 0 false Decibel Therapeutics, Inc. /s/ Laurence Reid, PhD Laurence Reid, PhD Chief Executive Officer 2020-11-12